Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
36
Employees on LinkedIn Updated Oct 15, 2026
Loading...

How Many Employees Does Galectin Therapeutics Have?

Galectin Therapeutics (GALT) has 36 employees according to LinkedIn, roughly flat (+0.0%) over the past three months. The LinkedIn count includes everyone who lists Galectin Therapeutics as their current employer, so it reflects workforce changes sooner than the 14 reported in Galectin Therapeutics’s most recent official filing.

With 36 employees, Galectin Therapeutics has a smaller workforce than industry peers like Amgen (41,827) and Gilead Sciences (14,851).

Is Galectin Therapeutics Growing or Shrinking?

Employee count is one of the most reliable leading indicators in alternative data: companies tend to hire before they grow and cut before they report weakness. AltIndex feeds Galectin Therapeutics’s headcount into the GALT AI Score alongside job postings, employee business outlook, and 20+ other signals.

For more on Galectin Therapeutics’s workforce, see its job postings, employee business outlook, and employee ratings. For a demand-side read, see Galectin Therapeutics web traffic.

Month over Month Linkedin Employees

Sep 2026 36
Aug 2026 36
Jul 2026 36
Jun 2026 36
May 2026 36
Get GALT alerts in real-time
The moment the linkedin employees trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Galectin Therapeutics Employees & Headcount: Frequently Asked Questions

Galectin Therapeutics has 36 employees according to LinkedIn, compared with 14 reported in its most recent official filings. The LinkedIn figure counts everyone who lists Galectin Therapeutics as their current employer, so it reflects workforce changes sooner than annual filings.

Galectin Therapeutics’s headcount has been broadly stable over the past three months. View the headcount trend chart above for the full history.

Headcount is a leading indicator: companies typically hire before revenue accelerates and reduce staff before earnings disappoint. No single data point predicts a stock on its own, which is why AltIndex combines Galectin Therapeutics’s headcount with job postings, employee business outlook, and 20+ other signals in its AI Score.

Galectin Therapeutics underperforms its industry peers when it comes to Linkedin Employees, ranking dead last.

Sign up and get more insights on Galectin Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.